Atlas Trials

CLG561 Proof-of-Concept Study as a Monotherapy and in Combination With LFG316 in Subjects With Geographic Atrophy (GA)

Clinical trial NCT02515942 · COMPLETED

Trial details

NCT number
NCT02515942
Sponsor
Alcon Research
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Geographic Atrophy
Start date
2015-09-25
Primary completion
2017-08-14
Enrollment
114

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.